Dec 7 2009
Shrink Nanotechnologies, Inc. ("Shrink") (OTCBB:INKN), an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors and biotechnology research and development tools businesses, today announced that a leading academic journal - Lab on a Chip - has published a paper profiling the Company's StemDisc technology in the October issue. Shrink's scientific advisors, Michelle Khine and Kara E. McCloskey, were key contributors to the research, which focused on the work done by Dr. Khine pertaining to the methodology for producing low-cost and portable microfluidic devices.
The article reports on the researchers' findings of an ultra-rapid fabrication and culture method for embryoid body (EB) formation utilizing a laser-jet printer to generate closely arrayed honeycomb microwells of tunable sizes for the induction of uniform EBs from single cell suspension. These microwells are easily adaptable and scalable to most standard well plates and easily integrated into commercial liquid handling systems to provide an inexpensive and easy high throughput compound screening platform.
"StemDisc has the ability to change the way research is conducted in labs worldwide. We are honored that scientists of this caliber have validated the value of the technology through their extensive research and published their findings in one of the top academic journals in this sector," said Mark L. Baum, CEO of Shrink Nanotechnologies. "We are currently working with a number of strategic manufacturers to commercialize products utilizing StemDisc and are excited to go to market in the first half of 2010."
Shrink is made up of some of the world's scientific leading minds - and includes a network of top experts in the fields of finance, industry, government, and academia. Drs. Khine and McCloskey are both members of Shrink's scientific advisory board. Khine is the scientific founder of Shrink's nanofabrication platform. She was recently named by MITTechnology Review as one of the top 35 global innovators under the age of 35 - and by Forbes' Revolutionaries Series, which recognizes radical thinkers and their world-changing ideas.
Dr. McCloskey is a professor at the School of Engineering, University of California, Merced. She has conducted significant research in the field of tissue engineering with a specific focus on the cardiovascular system and stem cells.
For further information on Shrink Nanotechnologies and StemDisc, and to be kept updated on company announcements, please visit www.shrinknano.com/rdbio.php and sign up for the Shrink Technology newsletter.